In partnership with
November 6, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators see the policy terrain before it shifts beneath their feet.
Democrats claimed key statehouses, giving Virginia and New Jersey a second chance to finish what they started. But while the political winds shift, the corporate fight over hemp beverages has gone thermonuclear. Coca-Cola and Nestlé just joined the lobbying coalition pressing Congress to ban THC drinks entirely, aligning with alcohol and MSO interests to freeze the market until incumbents can control it.
Our featured THC Group analysis unpacks how that coalition formed, what’s at stake, and why “regulation” has become code for “delay until acquisition.” And one quick correction from yesterday’s edition: the Wine & Spirits Wholesalers of America did not sign the hemp ban letter. That was my acronym mistake.
Today’s edition is supported by Go-To-Millions and Fintech Takes.
It has been a busy shutdown.
Growth unlocks straight to your inbox
You’re optimizing for growth. You need ecom tactics that actually work. Not mushy strategies.
Go-to-Millions is the ecommerce growth newsletter from Ari Murray, packed with tactical insights, smart creative, and marketing that drives revenue.
Every issue is built for operators: clear, punchy, and grounded in what’s working, from product strategy to paid media to conversion lifts.
Subscribe free and get your next growth unlock delivered weekly.
Start here — the day’s most important development, decoded for impact.
East Coast Wins Open Doors Democrats Still Have to Walk Through
🧾 Context: Abigail Spanberger crushed her opponent Tuesday and Democrats got Richmond back, which means Virginia can finally do what it legalized four years ago: actually sell weed. Youngkin vetoed retail bills twice with identical gang-activity fear mongering while possession stayed legal and unlicensed storefronts did whatever they wanted. The Cannabis Control Authority has been sitting on draft rules, Metrc contracts, and lab standards since Youngkin made clear he'd veto anything that moved. Mikie Sherrill won New Jersey promising to legalize home cultivation for both medical patients and adult-use, which is notable because Phil Murphy spent eight years pretending the issue didn't exist. The trade association flipped to supporting medical home grow last year after realizing patients paying $1,000 monthly weren't going to tolerate the ban forever, but Senate President Nick Scutari keeps blocking floor votes anyway. Pennsylvania didn't vote Tuesday, so Josh Shapiro is still pushing legalization at a Senate committee that won't give him a hearing.
🔎 What It Signals: Virginia now has the votes and the governor to pass retail legislation when the session opens January 14th, but passing a bill and opening dispensaries are completely different timelines. Building the regulatory infrastructure takes a year minimum: writing final rules, integrating Metrc, processing municipal decisions, hiring enforcement staff, scoring social equity applications. Virginia gets to do this while cleaning up four years of illicit retail that embedded itself while Republicans stalled. Can the Democrats pass anything, though? Or does this follow the typical budget hostage situation where equity funding and tax splits become negotiating chips? New Jersey home grow depends entirely on whether Sherrill can give Scutari enough cover through registration schemes and inspection authority to let him save face after years of blocking it. MSOs are quieter on home grow now because they've realized six-plant medical cultivation doesn't actually dent revenue when patients are desperate and prices average $269 per ounce. Pennsylvania is watching five of six neighbors collect adult-use revenue while Shapiro points out that 60% of border dispensary customers drive in from Pennsylvania, but Senate leadership isn't moving without extracting something structural in return. Rescheduling has been frozen since January in administrative appeals with no briefing schedule, no hearing date, and a DEA Administrator who promised to prioritize it but has filed three identical 90-day status reports saying nothing's happened.
🧠 THC Group Take: Virginia legislation moves fast but implementation grinds at government speed, and anyone expecting sales before late 2026 is confusing political wins with operational reality. We built Massachusetts regulations from scratch and twelve months was optimistic when we had legislative momentum, but on agency (yet). Virginia is starting with four years of illicit market entrenchment and all the equity fights that got postponed during the Youngkin vetoes. New Jersey home grow only happens if Sherrill trades enough restrictions to let Scutari pretend he's protecting public safety, which probably means registration requirements, surprise inspection language, and delayed effective dates that push implementation into 2027. The MSO position shift matters because it removes the loudest opponent, but don't mistake trade association statements for actual lobbying priorities when those same companies still benefit from supply control. Pennsylvania stays stuck until Senate committee leadership gets what they actually want, which looks like state-store involvement or pricing floors, not the bipartisan private-retail bill gathering dust since July. Rescheduling is a tax and banking compliance question for your general counsel, not a 2026 revenue catalyst, because the administrative process has no deadline and internal White House fights between political advisers who want the win and policy staff who hate cannabis haven't resolved. Virginia is the real opportunity here but only for operators who already invested in municipal relationships and regulatory buildout capacity, because that twelve-month implementation window gets eaten fast when agencies are writing rules, vendors are integrating systems, and municipalities are holding public hearings about whether to opt in.
📊 FEATURED ANALYSIS
THC Group published an in-depth analysis of the alcohol lobby's push to freeze hemp beverage sales while federal rules are written. The piece examines why the timing of the industry letter matters, who didn't sign it, and what Minnesota's early hemp beverage program reveals about actual market dynamics versus regulatory fears. The essay argues that responsible national standards should govern the market consumers have already chosen rather than pause adoption to benefit incumbents still preparing to compete. Read the full analysis →
Fast-moving headlines, flagged for what matters.
The Consumer Brands Association, whose members include Coca-Cola, General Mills, Kraft Heinz, Nestlé, and Target, sent Congress a letter backing Andy Harris's appropriations language to ban hemp products containing any quantifiable amount of THC. CBA claims intoxicating hemp beverages "can include more THC than ever intended" and products are deliberately marketed with cartoon imagery mimicking candy, creating investigative challenges and unseen health impacts. Target is a CBA member despite launching a pilot program weeks after the letter to sell hemp THC beverages at select Minnesota locations. The association joins alcohol industry groups, 39 state attorneys general, and cannabis MSOs in pushing federal hemp prohibition while Rand Paul threatens to block government funding if a full ban stays in appropriations legislation. When Coca-Cola and Nestlé lobby to protect consumers from unregulated intoxicating beverages, the concern is market competition rather than public health given both companies spent decades perfecting the art of marketing sugar water to children. (Marijuana Moment)
Steve Bevan, who worked directly with Mitch McConnell to draft the 2018 Farm Bill's hemp provisions, sent a letter to congressional leaders saying intoxicating hemp products weren't an accident. They specifically added language about extracts, derivatives, and cannabinoids to help Kentucky farmers reach markets, and McConnell knew exactly what that meant. Bevan says they asked FDA to create quality standards during the drafting process, FDA refused to act for two years, and now McConnell wants to ban the market his own legislative language created. The 39 attorneys general pushing for prohibition mostly serve states with legal cannabis programs losing tax revenue to hemp competitors. What's remarkable is how cleanly this exposes the actual fight: it's not about safety since those same states sell far more potent cannabis products legally, it's about which commercial interests get protected. (Marijuana Moment)
The Beer Institute joined cannabis MSOs at a Semafor conference pushing federal hemp restrictions, with CEO Brian Crawford arguing brewers face heavy regulation while THC beverages operate unchecked. Minnesota Attorney General Keith Ellison shocked the state's hemp industry by signing the 39-state letter calling for "prohibition on products containing intoxicating levels of THC - of any kind and no matter how it is derived," then backpedaled claiming he only wanted to stop bad actors. The letter would kill Minnesota's 2022 hemp law that created a $200 million industry, saved half of 240 craft breweries from pandemic closure, and established the regulatory model Cann now uses to sell in 30 states including Target. House Agriculture Committee language would criminalize any cannabinoid manufactured outside a hemp plant, making Minnesota's 10-milligram cap irrelevant by banning the entire category while beer sales crater among younger consumers choosing THC drinks instead. (MinnPost)
CoBank's new report projects cannabis beverage sales will reach $2.8 billion by 2028 with 16.9% CAGR, while at-home alcohol beverages limp along at 2.4% growth through 2030. Nearly half of Americans are trying to drink less in 2025, with sober-curious interest up 44% in two years, and a quarter of adults reporting zero alcohol consumption in 2024. The substitution effect is real: 56% of hemp beverage consumers report drinking less alcohol, with 21% quitting entirely, which means every percentage point of market share cannabis takes represents billions in lost alcohol revenue. When CoBank economists start modeling cannabis as a legitimate alcohol replacement category rather than a niche curiosity, that's the institutional finance world pricing in permanent demand shift. (BevNET)
Abigail Spanberger won Virginia's gubernatorial race Tuesday, giving the state its first governor since legalization who actually supports creating a retail market. Virginia has been stuck in regulatory purgatory since 2022 when possession became legal but sales remained banned, creating what's now a multibillion-dollar illicit market while outgoing Gov. Glenn Youngkin vetoed retail legislation in each of the last two sessions. Spanberger brings expanded Democratic House majorities with her and an existing Senate majority, plus a legislative commission that's been drafting retail legislation all year with plans to introduce a bill in the January 2026 session. Her opponent called cannabis a gateway drug and said employees who tested positive for THC would "blow everything up" working with gas and electricity. Spanberger's the former CIA officer and federal agent who voted twice for federal legalization in Congress, and she's framing retail regulation as a law enforcement issue requiring transparency and clear markets rather than continued prohibition. (Marijuana Moment)
Rep. Mikie Sherrill won New Jersey's gubernatorial race Tuesday, replacing Phil Murphy who repeatedly blocked home cultivation despite the state legalizing adult-use cannabis in 2020. New Jersey remains one of the only legal states prohibiting both adult-use and medical home grow, with Murphy claiming the market needs to mature first even as dozens of small cannabis businesses recently pushed legislators to allow cultivation. Sherrill explicitly supports home grow provisions and says the legislature knows they didn't get the law right, the cannabis companies know the law isn't right, and fixing it means addressing unregulated THC drinks in convenience stores alongside allowing home cultivation. She's a former federal prosecutor who voted twice for federal legalization in Congress and earned an A grade from NORML, which is a sharp contrast from her Republican opponent who called marijuana a gateway drug. The policy shift matters because Murphy's obstruction on home grow was always arbitrary: mature markets like Colorado and Oregon have had home cultivation from day one without collapsing their retail sectors. (Marijuana Moment)
Oklahoma's adult-use cannabis ballot initiative fell short of the 173,000 signatures needed by the November 3rd deadline, becoming the first petition casualty under new legislative restrictions passed in May. The law caps signatures at 20.8% per county, forcing campaigns to spread resources across rural areas instead of concentrating on Oklahoma City and Tulsa where most voters live. Oklahomans for Responsible Cannabis Action collected over 100,000 signatures across 500 locations statewide but couldn't overcome the new geographic distribution requirements that essentially require paid signature gathering operations rather than volunteer efforts. The campaign leader called out the absurdity directly: Harmon County residents can sign, but the law caps that county at 117 total signatures, which means traveling there becomes mathematically pointless. Oklahoma's legislature passed the most restrictive ballot access law in the country specifically to stop cannabis initiatives after voters approved medical marijuana over their objections, and it worked exactly as designed. (KOCO 5 News)
Nebraska Attorney General Mike Hilgers admitted Wednesday that the Omaha Tribe's tobacco tax compact was unworkable, confirming what the tribe alleged: he killed negotiations over their medical cannabis program. Hilgers called marijuana "a poison" that causes psychosis and crime, said the tribe wanted 90% of state tobacco revenue while offering nothing but law violations, and promised to station state law enforcement at the reservation border. The tribe's attorney general says Hilgers explicitly told him it was retaliation during a phone call an hour before their first cannabis commission meeting. Nebraska voters approved medical cannabis 71% last November but the state has no licensed dispensaries, while the tribe opened program enrollment last month under tribal sovereignty, creating the competitive threat that made a routine tax compact suddenly impossible. (WOWT)
South Dakota's Medical Marijuana Oversight Committee passed 11 motions Tuesday without making them public beforehand, without taking comment on individual motions, and with four of 11 members absent. Committee chair Rep. Josephine Garcia co-sponsored legislation earlier this year to repeal the entire medical marijuana program voters approved in 2020. When Genesis Farms' Emmett Reistroffer called the panel a "show committee" and questioned whether Garcia should chair oversight for a program she publicly opposed, Garcia muted his microphone twice during the two-minute public comment period. The motions include banning THC products in retail stores and giving law enforcement access to the prescription drug monitoring program, though nobody can quite figure out if these are proposed rules, draft legislation, or symbolic gestures. The spectacle came after an earlier meeting where Garcia invited out-of-state speakers to warn about marijuana dangers while licensed operators watched what felt like a coordinated dismantling attempt. (South Dakota Searchlight)
Most coverage tells you what happened. Fintech Takes is the free newsletter that tells you why it matters. Each week, I break down the trends, deals, and regulatory shifts shaping the industry — minus the spin. Clear analysis, smart context, and a little humor so you actually enjoy reading it.
From the hearing room to the comment section — we’re watching it all.
📊 Ohio Northern University polled 1,638 residents on attitudes toward controversial land uses and found marijuana dispensaries ranked ahead of AI data centers in public acceptance. Solar farms won at 55 percent support, followed by multi-family housing and dispensaries, which earned backing for economic benefits despite safety concerns. Cannabis now polls as more socially acceptable than cutting-edge tech infrastructure in Ohio zoning debates. (ABC6)